my cv om prakash 22-02-12
TRANSCRIPT
-
8/3/2019 My CV Om Prakash 22-02-12
1/6
My CVMR. OM PRAKASH MAURYA
[email protected], M- 9878038710
Working as Asst. Manager- Clinical Research & Regulatory Affairs in
Ind-swift Limited, R & D Centre, Panchkula, Haryana since January 2011.
Total Experience in Clinical Research: 5 Years 5 monts
Experience in Quantum Limited: 1.0 Year (1/8/06 to 21/07/07)
Experience in Torrent Research Centre: 3 year & 6 months (23/07/07 to13/01/11)
Current CTC= 4.5 lac pa
EDUCATIONAL DETAILS:-
Professional QualificationMaster of Pharmacy (Pharmacology)Name of the College : Poona College of PharmacyName of the University : Bharati Vidyapeeth Deemed UniversityPercentage of Marks : 67% (First class)
: Year of passing July 2006
Bachelor in Pharmacy (B. Pharm)Name of the College : Dept. of Pharmaceutical SciencesName of the University : HNB Garhwal University, Uttaranchal.
Percentage of Marks : 66.27% (First class) : Year of Passing 2004H. S. C. (12th )Name of the College : Govt. Inter College FaizabadBoard : Uttar Pradesh AllahabadPercentage of Marks : 61% (First class) : Year of Passing 1995S. S. C. (10th )Name of the College : Govt. Inter College FaizabadBoard : Uttar Pradesh AllahabadPercentage of Marks : 66.67% (First class)
: Year of Passing 1993
Other: GATE qualified with 86.56 percentile in 2004.
ADDITIONAL
Certificate ofICH GCP training from Vaatsalya Healthcare Solutions Pvt. Ltd.Bangalore.
Page 1 of 6
-
8/3/2019 My CV Om Prakash 22-02-12
2/6
My CV
EXPERIENCE DETAILS:
PROFILE IN Quantum Limited:Workedas a Technical Associate Officer (CRA) - Clinical Research in CRO-Quantum Limited (A Clinical Research Organization, Pune, Maharashtra) SinceAugust 2006 till July 2007.
Responsible for designing of clinical trial protocol, Case Report Form(CRF) and Informed Consent documents.
Site Screening/feasibility for various therapeutic segments (CNS, CVS,Arthritis Respiratory System and Colon Cancer) and monitoring of study.
Responsible for submitting the required documents for IRB/IEC approvaland DCGI approval.
Responsible for meeting with Principal Investigator and discus regarding
the study protocol. Responsible to discus with sponsor for the studies related matters.
Responsible for coordination of sites and management of trial supplyrequirement.
Responsible for preparation of Clinical Trial Report.
PROFILE IN Torrent Research Centre:BA/BE STUDIES
Protocol Designing& Review according to regulatory guidelines and in houseSOP for various kinds ofBA/BE studies. Key exp. as below.
App. 100 protocol designed for BA/BE studies for different regulatory
App. 60 CSR writing for regulatory submission
Pharmacokinetic/Pharmacodynamic end point study
Bioequivalence in psychiatric patients
Steady state study
Food effect study
Conventional BE study
Guidelines followed:
USFDA, ANVISA (Brazil), MHRA (UK), TGA, EMEA, DCGI and HealthCanada
Page 2 of 6
-
8/3/2019 My CV Om Prakash 22-02-12
3/6
My CV
CRF Designing & Review
Report writing and submission to various regulatory authorities within
timelines
Investigator Brochure preparation
SOP preparation and system up gradation
Audit face and Regulatory Query resolution
IEC responsibility
Organize meeting and approval procedures of Protocols, CRFsand ICFs
SAE reporting and Periodic safety reporting
LATE PHASE (III & IV) CLINICAL TRIALS
Protocol development
Essential Documents preparation and co-coordinating ethics approval
Site Screening/feasibility for various therapeutic segments (especiallyNeuropsychiatry, Cardiology)
Investigator Selection and site training (GCP and relevant regulatoryrequirements)
Site development
Periodic Monitoring
Source data verification and Data cleaning
Data management Preparation of Clinical report and submission to authority
Site close-out and regulatory compliance
Medical writing
CURRENT JOB RESPONSIBILITIES
Key Profile in Ind-Swift Limited
1. Planning and management of Bioequivalence studies for differentregulatory markets.
2. Planning and management of Phase III clinical studies for DCGIsubmission.
3. Review of Protocol, Report for BA/BE/Clinical Trial studies.4. Handling of Regulatory Queries.5. Selection of CRO for Bioequivalence and Clinical Trial studies.6. Monitoring of BA/BE/Clinical Trial studies.7. Review and Finalization of Clinical Expert (Module 2 and Module 5).
Page 3 of 6
-
8/3/2019 My CV Om Prakash 22-02-12
4/6
My CV
8. Checking of Dossier as per Different Regulatory requirements.9. Assistance to 3 to 4 team person for different aspects for Dossier.
Page 4 of 6
-
8/3/2019 My CV Om Prakash 22-02-12
5/6
My CV
SYMPOSIUM / CONFERENCES ATTENDED
Rheology of Pharmaceutical and Cosmetic Product organized on
Monday 18th Aug 2003 by Haake Instrument India Pvt. Ltd. Pune.
Seminar on Voltage gated ion channels by David J.Triggle,
Professor, School of Pharmacy and Pharmaceutical Sciences,
University of Buffalo, NY, USA, in Poona College of Pharmacy, Pune.
National seminar on trends in drug discovery Poona College of
Pharmacy, Pune.
National workshop on Clinical Trials: scope, challenge, regulation and
methodology of working in India sponsored by ICMR and conducted at
S.J Thakkar Pharmacy College, Rajkot on 15th Sept., 2007.
National workshop on Clinical Research and Regulatory Affairs
sponsored by ICMR and conducted at K.B. Institute of Pharmaceutical
Education and Research, Gandhinagar on 26th April 2008.
PERSONAL
Date of Birth : 8th March 1979Sex : MaleMarital Status : Married
Nationality : IndianLanguage : English, HindiHobbies : Reading, Listening Music and Traveling
Permanent Address Correspondence AddressS/O Sri Ram Achal Maurya C/17,Bhagwat Nagar Society.Vill - Muradabad Near Gulab Tower,Post Makhadoom Baramadpur Sola RoadDist Faizabad (U.P.) 224159 Thaltej,Phone - 9839174755 (Home) Ahmedabad, Gujarat
Place: AhmedabadMobile: 9974407556
Publication:
S.L. Bodhankar, P.A. Thakurdesai, Om Prakash Maurya. Effect of
Ondansetron (RS) and its Enantiomers in QTc interval in rats; Online
publication in Journal of Pharmacology, 2006.
Page 5 of 6
-
8/3/2019 My CV Om Prakash 22-02-12
6/6
My CV
HR Mehta, AS Srivastava, SK Shah, OP Maurya, S Manikumar and DS
Patel. Evaluation of Steady State Pharmacokinetics and Safety of
Duloxetine Major Depressive Patients After Multiple Dosing in Hospital Set
up. Pharma Science Monitor an International Journal of Pharmaceutical
sciences, Online Published (2010), www.pharmasm.com.
REFERENCES
1. Dr. Johesh MahajanIVP- Clinical ResearchLambda Therapeutics, Ahmedabad
2. Dr. Ambrish SrivastavaGM-Clinical ResearchTorrent Research Centre, Gandhinagar
3. Dr. Hardeep WadhwaPresident- Ind Swift limited
Om Prakash MauryaDate: 22/02/2012
Page 6 of 6
http://www.pharmasm.com/http://www.pharmasm.com/